Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress. Nyquist et al.
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
These are the uncropped western blots used in figures 3 and 4
本数据集包含用于图3与图4的未裁剪免疫印迹（Western Blot）结果
创建时间：
2020-05-14
